Largest study ever into health benefits and disadvantages of Ozempic: what have scientists discovered?

Scientists have examined data from as many as 2.4 million people with diabetes to find out exactly what impact glucagon-like peptide 1 receptor agonists have on our health. These types of substances are the main component of medicines such as Ozempic and Mounjaro. They announced their results yesterday in the scientific journal Nature Medicine. HLN science journalist Martijn Peters explains what the 42 health advantages and 19 disadvantages are.

ttn-3